In addition, along with well-established clinico-pathological factors (positive nodal status and large tumor diameter), the lack of CXCL13 expression and the expression of MUC1 in the tumor bed were identified as risk factors that are strongly associated with worse RFS and OS, respectively. Here, CXCL13 is linked to neoplasm.